Altogether, these results demonstrate that glioblastoma progression is driven by the integration of tumour cells in the vasculature, which relies on the capacity of cancer cells to undergo endothelialisation in response to TGF-β-Smad1/5 signaling activation. This evidence concerns the gene TGFB1 and glioblastoma.